Anna Giulia Loi

1.2k total citations
22 papers, 989 citations indexed

About

Anna Giulia Loi is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Anna Giulia Loi has authored 22 papers receiving a total of 989 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 12 papers in Virology and 9 papers in Molecular Biology. Recurrent topics in Anna Giulia Loi's work include HIV/AIDS drug development and treatment (19 papers), HIV Research and Treatment (12 papers) and Biochemical and Molecular Research (8 papers). Anna Giulia Loi is often cited by papers focused on HIV/AIDS drug development and treatment (19 papers), HIV Research and Treatment (12 papers) and Biochemical and Molecular Research (8 papers). Anna Giulia Loi collaborates with scholars based in Italy, France and United States. Anna Giulia Loi's co-authors include Paolo La Colla, Silvio Massa, Marino Artico, Romano Silvestri, Franca Scintu, Gabriella Martino, Ettore Novellino, Giovanni Greco, Antonella De Montis and Antonello Mai and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Anna Giulia Loi

21 papers receiving 962 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Giulia Loi Italy 15 667 395 241 222 143 22 989
Anna‐Maria Monforte Italy 19 798 1.2× 384 1.0× 290 1.2× 213 1.0× 100 0.7× 44 1.2k
Ayda Saldivar United States 14 314 0.5× 272 0.7× 281 1.2× 170 0.8× 137 1.0× 27 700
Tim H. M. Jonckers Belgium 17 412 0.6× 334 0.8× 383 1.6× 197 0.9× 194 1.4× 32 981
Theodore J. Nitz United States 19 453 0.7× 183 0.5× 384 1.6× 153 0.7× 97 0.7× 30 934
Pietro Monforte Italy 13 790 1.2× 266 0.7× 170 0.7× 136 0.6× 46 0.3× 26 978
Joseph W. Strohbach United States 15 470 0.7× 328 0.8× 230 1.0× 246 1.1× 61 0.4× 19 850
Hirohiko Sugimoto Japan 15 453 0.7× 547 1.4× 403 1.7× 456 2.1× 100 0.7× 36 1.1k
James P. Guare United States 14 546 0.8× 432 1.1× 425 1.8× 369 1.7× 81 0.6× 32 1.1k
Maria Elena Marongiu Italy 14 601 0.9× 229 0.6× 269 1.1× 140 0.6× 74 0.5× 27 941
Roger Guedj France 18 544 0.8× 366 0.9× 508 2.1× 199 0.9× 103 0.7× 60 1.1k

Countries citing papers authored by Anna Giulia Loi

Since Specialization
Citations

This map shows the geographic impact of Anna Giulia Loi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Giulia Loi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Giulia Loi more than expected).

Fields of papers citing papers by Anna Giulia Loi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Giulia Loi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Giulia Loi. The network helps show where Anna Giulia Loi may publish in the future.

Co-authorship network of co-authors of Anna Giulia Loi

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Giulia Loi. A scholar is included among the top collaborators of Anna Giulia Loi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Giulia Loi. Anna Giulia Loi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pierra, Claire, S. Benzaria, David Dukhan, et al.. (2004). Synthesis, Physicochemical and Pharmacokinetic Studies of Potential Prodrugs of β-L-2′-Deoxycytidine, a Selective and Specific Anti-HBV Agent. Antiviral chemistry & chemotherapy. 15(5). 269–279. 3 indexed citations
2.
Silvestri, Romano, Gabriella Martino, Giuseppe La Regina, et al.. (2003). Novel Indolyl Aryl Sulfones Active against HIV-1 Carrying NNRTI Resistance Mutations:  Synthesis and SAR Studies. Journal of Medicinal Chemistry. 46(12). 2482–2493. 150 indexed citations
3.
Sheikha, Ghassan Abu, Paolo La Colla, & Anna Giulia Loi. (2002). A NEW CLASS OF ACYCLIC NUCLEOSIDE PHOSPHONATES: SYNTHESIS AND BIOLOGICAL ACTIVITY OF 9-{[(PHOSPHONOMETHYL)AZIRIDIN-1-YL]METHYL}GUANINE (PMAMG) AND ANALOGUES. Nucleosides Nucleotides & Nucleic Acids. 21(10). 619–635. 20 indexed citations
4.
Silvestri, Romano, Marino Artico, Gabriella Martino, et al.. (2000). Computer-assisted design, synthesis and biological evaluation of novel pyrrolyl heteroaryl sulfones targeted at HIV-1 reverse transcriptase as non-nucleoside inhibitors. Bioorganic & Medicinal Chemistry. 8(9). 2305–2309. 14 indexed citations
5.
Cretton-Scott, Erika, L Placidi, Abdesslem Faraj, et al.. (2000). In Vitro and In Vivo Metabolism and Pharmacokinetics ofbis[(T-Butyl)-S-acyl-2-thioethyl]-β-L-2′,3′-dideoxy-5-fluorocytidine Monophosphate. Nucleosides Nucleotides & Nucleic Acids. 19(1-2). 481–499. 6 indexed citations
6.
Pierra, Claire, Jean‐Louis Imbach, Erik De Clercq, et al.. (2000). Synthesis and antiviral evaluation of some β-l-2′,3′-dideoxy-5-chloropyrimidine nucleosides and pronucleotides. Antiviral Research. 45(3). 169–183. 11 indexed citations
7.
Artico, Marino, Romano Silvestri, Ettore Novellino, et al.. (2000). Structure-Based Design, Synthesis, and Biological Evaluation of Novel Pyrrolyl Aryl Sulfones:  HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors Active at Nanomolar Concentrations. Journal of Medicinal Chemistry. 43(9). 1886–1891. 119 indexed citations
8.
Diana, Patrizia, Paola Barraja, Antonino Lauria, et al.. (1999). ChemInform Abstract: 2‐Triazenopyrroles: Synthesis and Biological Activity.. ChemInform. 30(47).
9.
Mai, Antonello, Marino Artico, Gianluca Sbardella, et al.. (1999). 5-Alkyl-2-(alkylthio)-6-(2,6-dihalophenylmethyl)-3,4-dihydropyrimidin-4(3H)-ones:  Novel Potent and Selective Dihydro-alkoxy-benzyl-oxopyrimidine Derivatives. Journal of Medicinal Chemistry. 42(4). 619–627. 98 indexed citations
10.
Diana, Patrizia, Paola Barraja, Antonino Lauria, et al.. (1999). 2-Triazenopyrroles: synthesis and biological activity. European Journal of Medicinal Chemistry. 34(4). 353–360. 16 indexed citations
11.
Almerico, Anna Maria, Patrizia Diana, Paola Barraja, et al.. (1998). Glycosidopyrroles Part 1. Acyclic derivatives: 1-(2-hydroxyethoxy) methylpyrroles as potential anti-viral agents. Il Farmaco. 53(1). 33–40. 41 indexed citations
12.
Franchetti, Palmarisa, Loredana Cappellacci, Ghassan Abu Sheikha, et al.. (1997). Synthesis, Structure, and Antiproliferative Activity of Selenophenfurin, an Inosine 5‘-Monophosphate Dehydrogenase Inhibitor Analogue of Selenazofurin. Journal of Medicinal Chemistry. 40(11). 1731–1737. 61 indexed citations
13.
Mai, Antonello, Marino Artico, Gianluca Sbardella, et al.. (1997). Dihydro(alkylthio)(naphthylmethyl)oxopyrimidines:  Novel Non-Nucleoside Reverse Transcriptase Inhibitors of the S-DABO Series. Journal of Medicinal Chemistry. 40(10). 1447–1454. 92 indexed citations
14.
Artico, Marino, Roberto Di Santo, Roberta Costi, et al.. (1997). 1-Arylsulfonyl-3-(α-hydroxybenzyl)-1H-pyrroles, a novel class of anti-HIV-1 reverse transcriptase inhibitors. Bioorganic & Medicinal Chemistry Letters. 7(14). 1931–1936. 11 indexed citations
15.
Artico, Marino, Romano Silvestri, G. STEFANCICH, et al.. (1996). 5H-pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs): A novel class of non-nucleoside reverse transcriptase inhibitors. Bioorganic & Medicinal Chemistry. 4(6). 837–850. 38 indexed citations
16.
Artico, Marino, Romano Silvestri, Silvio Massa, et al.. (1996). 2-Sulfonyl-4-chloroanilino Moiety:  A Potent Pharmacophore for the Anti-Human Immunodeficiency Virus Type 1 Activity of Pyrrolyl Aryl Sulfones. Journal of Medicinal Chemistry. 39(2). 522–530. 120 indexed citations
17.
Pompon, Alain, Jean‐Luc Girardet, Loredana Cappellacci, et al.. (1996). Decomposition Pathways and in Vitro HIV Inhibitory Effects of IsoddA Pronucleotides:  Toward a Rational Approach for Intracellular Delivery of Nucleoside 5‘-Monophosphates. Journal of Medicinal Chemistry. 39(10). 1981–1990. 80 indexed citations
18.
Franchetti, Palmarisa, Ghassan Abu Sheikha, Loredana Cappellacci, et al.. (1995). Synthesis and Antiviral Activity of 8-Aza Analogs of Chiral [2-(Phosphonomethoxy)propyl]guanines. Journal of Medicinal Chemistry. 38(20). 4007–4013. 22 indexed citations
19.
Massa, Silvio, Federico Corelli, Marino Artico, et al.. (1995). [[[(Thienylcarbonyl)alkyl]oxy]phenyl]- and [[[(Pyrrylcarbonyl)alkyl]oxy]phenyl]oxazoline Derivatives with Potent and Selective Antihuman Rhinovirus Activity. Journal of Medicinal Chemistry. 38(5). 803–809. 6 indexed citations
20.
Franchetti, Palmarisa, Loredana Cappellacci, Mario Grifantini, et al.. (1994). Synthesis and Evaluation of the Anti-HIV Activity of Aza and Deaza Analogs of IsoddA and Their Phosphates as Prodrugs. Journal of Medicinal Chemistry. 37(21). 3534–3541. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026